The Latest Cardiac and Vascular News
DENVER–(BUSINESS WIRE)–Cleerly, a leader in AI-based cardiovascular imaging, will showcase new product updates at RSNA 2025, November 30 – December 4, 2025, at McCormick Place in Chicago, IL. At Booth #8039, Cleerly will demonstrate PowerScribe integration and newly added lesion-level reporting, discuss new clinical research findings, and provide guidance on the […]
SYDNEY, Nov. 24, 2025 (GLOBE NEWSWIRE) — AI and Medical Technology Company Echo IQ Limited (ASX: EIQ) (“Echo IQ” or “the Company”) is pleased to advise that it has completed its clinical validation for its heart failure clinical decision support software (“EchoSolv HF”) in collaboration with the Mayo Clinic Platform (“MCP”), a division of the Mayo Clinic, a top ranked US hospital. The MCP Validate program is a unique in-market AI evaluation program which generates an independent and objective report on accuracy, efficacy and susceptibility to bias for AI-based decision software (refer ASX Announcement 1 July 2025).
IRVINE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) — JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced results from an expanded cohort of 700 patients from the ALIGN-AR pivotal trial for the Trilogy THV System in high-risk patients with symptomatic, severe aortic regurgitation (AR). These results were published in The Lancet and simultaneously presented as part of the Late-Breaking Clinical Trial sessions at PCR London Valves.
TeraRecon AV™ delivers advanced imaging visualization with AI-driven automations, enhancing clinician diagnostic precision and patient care while reducing manual efforts. It introduces advanced structural heart imaging simulations in a single solution, including Transcatheter Tricuspid Valve Replacement (TTVR), Transcatheter Mitral Valve Repair (TMVR), and Advanced Left Atrial Appendage (LAA) procedures, along […]
The second issue of the open-access journal showcases multidisciplinary heart failure research and the many intersections that shape patient care. WASHINGTON, Nov. 19, 2025 /PRNewswire/ — The second issue of the Journal of Cardiac Failure-Intersections, online now, delivers a diverse…
LIÈGE, Belgium & BEDFORD, Mass.–(BUSINESS WIRE)–CryoTherapeutics, a medical device company developing minimally invasive localized cryotherapy for the treatment of coronary artery disease, today announced a unique three-way collaboration with SpectraWAVE, an innovator in intravascular imaging and physiology and the Cardiovascular Research Foundation (CRF), the global leader in cardiovascular research, to […]
Designation underscores the potential for VS-041 to address a significant unmet medical need and potentially improve diagnosis by utilizing a serum biomarker VS-041 is being evaluated in a Phase 1c study of participants with HFpEF and elevated serum endotrophin ENCINITAS, Calif., and…
PESHAWAR, Pakistan, Nov. 13, 2025 /PRNewswire/ — The Peshawar Institute of Cardiology – Medical Teaching Institute (PIC-MTI) hosted a high-profile Radiology Continuing Medical Education (CME) session on “Innovations in Cardiovascular Imaging,” drawing senior cardiologists, radiologists,…
The world first AI Software for real-time intra-operative guidance of transcatheter heart valve implantation NICE, France–(BUSINESS WIRE)–Caranx Medical (“Caranx”), a French medical device company specializing in the development of an autonomous robot to democratize access to Transcatheter Aortic Valve Implantation (TAVI), a lifesaving procedure, today announced the first clinical use […]
IRVINE, Calif., Nov. 17, 2025 (GLOBE NEWSWIRE) — JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced the completion of its 1,000th commercial Trilogy procedure, performed in Cologne, Germany, marking a major milestone demonstrating the platform’s growing adoption in treating patients with symptomatic, severe aortic regurgitation (AR) who previously had limited treatment options.
